Programme : Back to Dr Jan Carsten Pieck

cHTS process @ MERCK KGaA


In 2015 we decided to start combinational screening approaches in a higher throughput format for the identification of syngergistic compound effects in the early preclinic research. In this poster a process and infrastructure overview is given for the well established cHTS approach at Merck KGaA.
Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018